SKI Market

Indian Indices

Sensex

84,818.22 143.14
( 0.17%)

Global Indices

Nasdaq

48,381.01 -101.93
(-0.21%)

Dow Jones

6,916.41 -10.33
(-0.15%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,948.02 81.49
(0.83%)

Forex

USD-INR

89.89 0.08
(0.09%)

EUR-INR

105.79 0.08
(0.08%)

GBP-INR

121.32 0.14
(0.12%)

JPY-INR

0.58 0.00
(0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Wanbury Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524212

INE107F01022

30.7353273

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WANBURY

16.06

805.13

EPS(TTM)

Face Value()

Div & Yield %

14.37

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	599.51	577.74	499.65	511.19	392.52	367.45
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	599.51	577.74	499.65	511.19	392.52	367.45
Other Income	3.49	0.90	0.91	77.88	2.40	83.78
Stock Adjustments	-1.51	3.89	-29.13	24.79	7.20	-5.99
Total Income	601.49	582.53	471.43	613.86	402.12	445.24
EXPENDITURE :
Raw Materials	292.96	307.48	274.31	325.07	228.53	169.75
Power & Fuel Cost	24.24	25.17	20.59	18.41	17.13	15.38
Employee Cost	104.24	86.92	81.00	74.81	64.15	67.48
Other Manufacturing Expenses	13.76	13.32	11.43	12.66	9.98	13.77
Selling & Administrative Expenses	64.78	58.71	45.16	55.34	45.49	55.36
Miscellaneous Expenses	21.71	17.93	15.45	14.36	16.42	16.29
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	521.69	509.54	447.94	500.65	381.70	338.02
Operating Profit	79.81	72.99	23.49	113.19	20.42	107.23
Interest	36.95	29.18	21.39	20.61	23.07	32.87
Gross Profit	42.86	43.81	2.10	92.58	-2.65	74.36
Depreciation	13.31	13.03	12.38	11.45	9.75	9.68
Profit Before Tax	29.55	30.78	-10.28	81.13	-12.40	64.68
Tax	5.86	0.00	0.00	0.00	2.27	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-6.84	0.38	0.11	-0.35	-2.07	0.21
Reported Net Profit	30.53	30.40	-10.40	81.47	-12.61	64.46
Extraordinary Items	1.37	0.49	-0.31	76.06	1.21	82.62
Adjusted Net Profit	29.16	29.91	-10.09	5.41	-13.82	-18.16
Adjustment below Net Profit	-0.38	-0.59	0.26	0.80	-0.44	-0.46
P & L Balance brought forward	-138.34	-168.14	-158.01	-240.28	-227.23	-291.23
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-108.19	-138.34	-168.14	-158.01	-240.28	-227.23
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	9.32	9.28	-3.18	24.94	-5.04	25.79
Earnings Per Share(Adj)-Unit Curr	9.32	9.28	-3.18	24.94	-5.04	25.79
Book Value-Unit Curr	16.26	6.70	-2.26	0.57	-52.23	-47.14
Book Value(Adj)-Unit Curr	16.26	6.70	-2.26	0.57	-52.23	-47.14

84,818.22 143.14 ( 0.17%)

48,381.01 -101.93 (-0.21%)

6,916.41 -10.33 (-0.15%)

50,384.39 -142.53 (-0.28%)

9,948.02 81.49 (0.83%)

89.89 0.08 (0.09%)

105.79 0.08 (0.08%)

121.32 0.14 (0.12%)

0.58 0.00 (0.34%)